Mental training program helps ease chemobrain in breast cancer
the ONA take:
A new program developed by UCLA researchers may ease post-treatment cognitive difficulties, better known as “chemo brain”, in patients with breast cancer, according to a study published in Psycho-Oncology.
In a randomized clinical trial, researchers led by Patricia Ganz, MD, built upon prior research that found a connection between neuro-psychological test performance and memory complaints in women being treated for early-stage breast cancer.
“We invited the women to participate in a research study that assigned them to early or delayed treatment with a five-week, two-hour group training session, where a psychologist taught them strategies to help them with their memory and maintaining their ability to pay attention to things,” Dr. Ganz said.
All the women who enrolled completed questions about their mood and mental functioning in follow-up testing.
Ganz and her fellow researchers found that women in the early intervention group reported improvements in memory complaints and test functioning, while those in the delayed group did not improve in either category.
“We hope that this might be an effective biologic way to assess the cognitive effects of cancer treatment in the future.”
A new program developed by UCLA researchers may ease post-treatment “chemo brain” in patients with breast cancer.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|